NEUREN PHARMACEUTICALS LIMITED - Announcements

5.25%

$13.17

Market Cap $1.651B

Healthcare Biotechnology

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run.

Announcements

Filter Results

All Price Sensitive Only

NEU	Update - Notification of buy-back - NEU		08:26	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		12/06/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		11/06/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		10/06/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		06/06/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		05/06/25	15.43KB	Share
NEU	Notification of cessation of securities - NEU		04/06/25	12.92KB	Share
NEU	Update - Notification of buy-back - NEU		04/06/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		03/06/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		02/06/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		30/05/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		29/05/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		28/05/25	15.43KB	Share
NEU	Results of Meeting		27/05/25	8.58KB	Share
NEU	AGM Chair Address & CEO Presentation	PRICE SENSITIVE	27/05/25	3.29MB	Share
NEU	Update - Notification of buy-back - NEU		27/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		26/05/25	15.44KB	Share
NEU	Notification regarding unquoted securities - NEU		23/05/25	18.85KB	Share
NEU	Approval of long-term equity incentive		23/05/25	178.68KB	Share
NEU	Update - Notification of buy-back - NEU		23/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		22/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		21/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		20/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		19/05/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		16/05/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		15/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		14/05/25	15.44KB	Share
NEU	NEU receives FDA minutes and re-confirms Phase 3 endpoints		13/05/25	161.63KB	Share
NEU	Update - Notification of buy-back - NEU		13/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		12/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		09/05/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		08/05/25	15.44KB	Share
NEU	DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024	PRICE SENSITIVE	08/05/25	238.53KB	Share
NEU	Update - Notification of buy-back - NEU		07/05/25	15.44KB	Share
NEU	Notification of cessation of securities - NEU		06/05/25	12.89KB	Share
NEU	Update - Notification of buy-back - NEU		06/05/25	15.43KB	Share
NEU	Becoming a substantial holder		05/05/25	757.8KB	Share
NEU	Update - Notification of buy-back - NEU		05/05/25	15.43KB	Share
NEU	Neuren appoints Daryl DeKarske to executive team		02/05/25	155.57KB	Share
NEU	Update - Notification of buy-back - NEU		02/05/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		01/05/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		30/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		29/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		28/04/25	15.43KB	Share
NEU	Virtual AGM online guide		24/04/25	305.83KB	Share
NEU	Notice of Annual General Meeting/Proxy Form		24/04/25	985.91KB	Share
NEU	Update - Notification of buy-back - NEU		24/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		23/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		22/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		17/04/25	15.44KB	Share
NEU	Change of Director's Interest Notice - J Basile		16/04/25	178.46KB	Share
NEU	NEU confirms primary endpoints for Phase 3 trial in PMS	PRICE SENSITIVE	14/04/25	167.14KB	Share
NEU	Update - Notification of buy-back - NEU		07/04/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		04/04/25	15.43KB	Share
NEU	Notification of cessation of securities - NEU		03/04/25	12.89KB	Share
NEU	Update - Notification of buy-back - NEU		03/04/25	15.43KB	Share
NEU	Appendix 4G		03/04/25	274.9KB	Share
NEU	2024 Annual Report to shareholders		03/04/25	1.8MB	Share
NEU	Update - Notification of buy-back - NEU		02/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		01/04/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		31/03/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		28/03/25	15.44KB	Share
NEU	Neuren initiates development of NNZ-2591 to treat HIE	PRICE SENSITIVE	27/03/25	165.4KB	Share
NEU	Update - Notification of buy-back - NEU		27/03/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		26/03/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		25/03/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		24/03/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		21/03/25	15.44KB	Share
NEU	Update - Notification of buy-back - NEU		20/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		19/03/25	15.42KB	Share
NEU	Update - Notification of buy-back - NEU		18/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		17/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		14/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		13/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		12/03/25	15.43KB	Share
NEU	Becoming a substantial holder		12/03/25	895.3KB	Share
NEU	Application for quotation of securities - NEU		11/03/25	14.25KB	Share
NEU	Update - Notification of buy-back - NEU		11/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		10/03/25	15.43KB	Share
NEU	Notification of cessation of securities - NEU		07/03/25	12.89KB	Share
NEU	Update - Notification of buy-back - NEU		07/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		06/03/25	15.43KB	Share
NEU	Ceasing to be a substantial holder		06/03/25	191.06KB	Share
NEU	Update - Notification of buy-back - NEU		05/03/25	15.43KB	Share
NEU	Update - Notification of buy-back - NEU		04/03/25	15.43KB	Share
NEU	Notification of cessation of securities - NEU		03/03/25	12.8KB	Share
NEU	2024 Full Year Results webinar		28/02/25	1.19MB	Share
NEU	Neuren receives DAYBUE sales milestone payment of US$50m	PRICE SENSITIVE	28/02/25	209.92KB	Share
NEU	2024 results - A$166m comprehensive income for shareholders	PRICE SENSITIVE	28/02/25	331.89KB	Share
NEU	Appendix 4E and 2024 full year accounts	PRICE SENSITIVE	28/02/25	373.96KB	Share
NEU	Neuren 2024 results investor webinar on 28 February 2025		27/02/25	158.69KB	Share
NEU	DAYBUE (trofinetide) 2024 net sales US$348 million	PRICE SENSITIVE	27/02/25	230.36KB	Share
NEU	Becoming a substantial holder		25/02/25	277.14KB	Share
NEU	Neuren receives Rare Pediatric Disease Designation from FDA	PRICE SENSITIVE	24/02/25	155.8KB	Share
NEU	Fast Track granted by FDA for NNZ-2591 in Pitt Hopkins	PRICE SENSITIVE	19/02/25	213.15KB	Share
NEU	Priority Review Voucher sale proceeds received	PRICE SENSITIVE	07/02/25	154.98KB	Share
NEU	Type C Meeting granted by FDA for Phelan-McDermid syndrome		07/02/25	155.37KB	Share
NEU	Neuren to present at autism research meeting		06/02/25	259.26KB	Share
NEU	NEU Presentations at ACMG Annual Clinical Genetics Meeting		22/01/25	267.42KB	Share
NEU	J.P. Morgan Healthcare Conference recap		20/01/25	160.21KB	Share

NEU Update - Notification of buy-back - NEU
08:26		15.43KB	Share
NEU Update - Notification of buy-back - NEU
12/06/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
11/06/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
10/06/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
06/06/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
05/06/25		15.43KB	Share
NEU Notification of cessation of securities - NEU
04/06/25		12.92KB	Share
NEU Update - Notification of buy-back - NEU
04/06/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
03/06/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
02/06/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
30/05/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
29/05/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
28/05/25		15.43KB	Share
NEU Results of Meeting
27/05/25		8.58KB	Share
NEU AGM Chair Address & CEO Presentation
27/05/25	PRICE SENSITIVE	3.29MB	Share
NEU Update - Notification of buy-back - NEU
27/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
26/05/25		15.44KB	Share
NEU Notification regarding unquoted securities - NEU
23/05/25		18.85KB	Share
NEU Approval of long-term equity incentive
23/05/25		178.68KB	Share
NEU Update - Notification of buy-back - NEU
23/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
22/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
21/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
20/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
19/05/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
16/05/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
15/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
14/05/25		15.44KB	Share
NEU NEU receives FDA minutes and re-confirms Phase 3 endpoints
13/05/25		161.63KB	Share
NEU Update - Notification of buy-back - NEU
13/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
12/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
09/05/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
08/05/25		15.44KB	Share
NEU DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024
08/05/25	PRICE SENSITIVE	238.53KB	Share
NEU Update - Notification of buy-back - NEU
07/05/25		15.44KB	Share
NEU Notification of cessation of securities - NEU
06/05/25		12.89KB	Share
NEU Update - Notification of buy-back - NEU
06/05/25		15.43KB	Share
NEU Becoming a substantial holder
05/05/25		757.8KB	Share
NEU Update - Notification of buy-back - NEU
05/05/25		15.43KB	Share
NEU Neuren appoints Daryl DeKarske to executive team
02/05/25		155.57KB	Share
NEU Update - Notification of buy-back - NEU
02/05/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
01/05/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
30/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
29/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
28/04/25		15.43KB	Share
NEU Virtual AGM online guide
24/04/25		305.83KB	Share
NEU Notice of Annual General Meeting/Proxy Form
24/04/25		985.91KB	Share
NEU Update - Notification of buy-back - NEU
24/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
23/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
22/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
17/04/25		15.44KB	Share
NEU Change of Director's Interest Notice - J Basile
16/04/25		178.46KB	Share
NEU NEU confirms primary endpoints for Phase 3 trial in PMS
14/04/25	PRICE SENSITIVE	167.14KB	Share
NEU Update - Notification of buy-back - NEU
07/04/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
04/04/25		15.43KB	Share
NEU Notification of cessation of securities - NEU
03/04/25		12.89KB	Share
NEU Update - Notification of buy-back - NEU
03/04/25		15.43KB	Share
NEU Appendix 4G
03/04/25		274.9KB	Share
NEU 2024 Annual Report to shareholders
03/04/25		1.8MB	Share
NEU Update - Notification of buy-back - NEU
02/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
01/04/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
31/03/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
28/03/25		15.44KB	Share
NEU Neuren initiates development of NNZ-2591 to treat HIE
27/03/25	PRICE SENSITIVE	165.4KB	Share
NEU Update - Notification of buy-back - NEU
27/03/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
26/03/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
25/03/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
24/03/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
21/03/25		15.44KB	Share
NEU Update - Notification of buy-back - NEU
20/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
19/03/25		15.42KB	Share
NEU Update - Notification of buy-back - NEU
18/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
17/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
14/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
13/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
12/03/25		15.43KB	Share
NEU Becoming a substantial holder
12/03/25		895.3KB	Share
NEU Application for quotation of securities - NEU
11/03/25		14.25KB	Share
NEU Update - Notification of buy-back - NEU
11/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
10/03/25		15.43KB	Share
NEU Notification of cessation of securities - NEU
07/03/25		12.89KB	Share
NEU Update - Notification of buy-back - NEU
07/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
06/03/25		15.43KB	Share
NEU Ceasing to be a substantial holder
06/03/25		191.06KB	Share
NEU Update - Notification of buy-back - NEU
05/03/25		15.43KB	Share
NEU Update - Notification of buy-back - NEU
04/03/25		15.43KB	Share
NEU Notification of cessation of securities - NEU
03/03/25		12.8KB	Share
NEU 2024 Full Year Results webinar
28/02/25		1.19MB	Share
NEU Neuren receives DAYBUE sales milestone payment of US$50m
28/02/25	PRICE SENSITIVE	209.92KB	Share
NEU 2024 results - A$166m comprehensive income for shareholders
28/02/25	PRICE SENSITIVE	331.89KB	Share
NEU Appendix 4E and 2024 full year accounts
28/02/25	PRICE SENSITIVE	373.96KB	Share
NEU Neuren 2024 results investor webinar on 28 February 2025
27/02/25		158.69KB	Share
NEU DAYBUE (trofinetide) 2024 net sales US$348 million
27/02/25	PRICE SENSITIVE	230.36KB	Share
NEU Becoming a substantial holder
25/02/25		277.14KB	Share
NEU Neuren receives Rare Pediatric Disease Designation from FDA
24/02/25	PRICE SENSITIVE	155.8KB	Share
NEU Fast Track granted by FDA for NNZ-2591 in Pitt Hopkins
19/02/25	PRICE SENSITIVE	213.15KB	Share
NEU Priority Review Voucher sale proceeds received
07/02/25	PRICE SENSITIVE	154.98KB	Share
NEU Type C Meeting granted by FDA for Phelan-McDermid syndrome
07/02/25		155.37KB	Share
NEU Neuren to present at autism research meeting
06/02/25		259.26KB	Share
NEU NEU Presentations at ACMG Annual Clinical Genetics Meeting
22/01/25		267.42KB	Share
NEU J.P. Morgan Healthcare Conference recap
20/01/25		160.21KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $13.17		Change -0.730(5.25%)		Mkt cap ! $1.651B

Open	High	Low	Value	Volume
$13.95	$13.96	$13.10	$2.890M	215.3K

Buyers (Bids)

No.	Vol.	Price($)
2	188	$13.15

Sellers (Offers)

Price($)	Vol.	No.
$13.18	64	2

View Market Depth

No.	Vol.	Price($)
2	82	13.160
4	402	13.150
7	497	13.140
4	428	13.130
5	640	13.120

Price($)	Vol.	No.
13.180	115	4
13.190	529	4
13.200	816	7
13.210	645	6
13.220	1137	4

Last trade - 12.04pm 13/06/2025 (20 minute delay)


Last $13.17		Change -0.730 ( 5.94 %)
Open	High	Low	Volume
$13.84	$13.87	$13.11	62069
Last updated 12.22pm 13/06/2025 ?

NEU (ASX) Chart

NEUREN PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

New Analyst Report Lifts Almonty Target Price to CDN$5.50

Top Stories